On 11/23/2019, the long anticipated NAPPA technology is finally published online in Advanced Science, providing details of how highly complicated multi-specific antibody can be produced by instant self-assembly from individual, separately prepared modules, as well as direct evidences that these self-assembled multi-specific antibodies are perfectly stable and active in redirecting T cells in vivo to kill tumor cells.



click here for the full paper